StarLIMS wins FDA software deal
News Feb 01, 2012
StarLIMS Ltd. has begun installing the company's software-based laboratory information management system (LIMS) with the US Food and Drug Administration (FDA) to enhance its testing laboratories for food and drug chemistries, devices, forensics material and microbiology samples.
The software will be used to manage complex processes and the analysis of the vast amounts of information generated by FDA laboratories. The LIMS solution will provide the needed capability to manage the analytical workflow operations in FDA’s Office of Regulatory Affairs 14 labs for approximately 825 users supporting sample accountability, data analysis, document control, report generation, and other lab operation functions.
“We’re looking forward to working on this important initiative,” said StarLIMS head Isaac Friedman. “STARLIMS has a successful track record in implementing web-based LIMS for life sciences organizations, public health laboratories and a number of federal agencies."
Isaac Friedman and his brother Chaim founded StarLIMS and took it public on the Tel Aviv Stock Exchange (TASE) and Nasdaq, before selling the company to Abbott Laboratories Inc. (NYSE: ABT).
Scientists at Tokyo Tech, Ricoh co. and The National Institute of Advanced Industrial Science and Technology have developed an ultra-low-power atomic clock (ULPAC) for small satellites to enable future communication systems beyond 5G. The proposed device outperforms the current industry standards in various benchmarks, such as size, stability, and power consumption.
With their ability to treat a wide a variety of diseases, spherical nucleic acids are poised to revolutionize medicine. But before these digitally designed nanostructures can reach their full potential, researchers need to optimize their various components. A team has developed a direct route to optimize these particles, bringing them one step closer to becoming a viable treatment option for numerous diseases, including cancer.READ MORE